Deana Knighten
Family · Lake Charles, LANPI 1083960355
Payments from drug & device makers
Across 114 payments — averaging $19.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$751
- Boston Scientific$179
- Novo Nordisk$141
- Boehringer Ingelheim$124
- Lilly USA, LLC$114
- Esperion Therapeutics, Inc.$111
- plus $786 from 19 others
What the payments were for
- Food & beverage$2,207100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 58 | $751 |
| Boston Scientific | 5 | $179 |
| Novo Nordisk | 3 | $141 |
| Boehringer Ingelheim | 2 | $124 |
| Lilly USA, LLC | 6 | $114 |
| Esperion Therapeutics, Inc. | 1 | $111 |
| Ardelyx, Inc. | 5 | $110 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 5 | $85 |
| Idorsia Pharmaceuticals US Inc | 1 | $73 |
| Bard Peripheral Vascular, Inc. | 1 | $62 |
| Abbott | 4 | $62 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $51 |
| Novartis | 3 | $47 |
| Axsome Therapeutics, Inc. | 2 | $45 |
| Alkermes, Inc. | 2 | $44 |
| Pfizer | 2 | $37 |
| AstraZeneca | 2 | $32 |
| Amgen | 2 | $31 |
| Astellas Pharma US Inc | 1 | $18 |
| GSK | 1 | $17 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $17 |
| Genentech USA, Inc. | 1 | $16 |
| Merck | 1 | $15 |
| Bayer | 1 | $14 |
| Otsuka America Pharmaceutical, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,207 in reported general payments places this provider in the 75th percentile of 3,610 family providers in Louisiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 91 | $90,678 |
| MounjaroTirzepatide | 78 | $84,453 |
| JardianceEmpagliflozin | 88 | $75,621 |
| FarxigaDapagliflozin Propanediol | 91 | $70,584 |
| TrulicityDulaglutide | 53 | $48,806 |
| LinzessLinaclotide | 47 | $33,748 |
| Repatha SureclickEvolocumab | 38 | $19,926 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 15 | $11,875 |
| SymbicortBudesonide/Formoterol Fumarate | 42 | $9,381 |
| XareltoRivaroxaban | 14 | $8,329 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 17 | $7,864 |
| VascepaIcosapent Ethyl | 12 | $4,537 |
| DuleraMometasone/Formoterol | 11 | $3,917 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 35 | $3,072 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 104 | $2,613 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $114 | $133,259131 claims |
| AstraZenecaFarxiga, Breztri Aerosphere, Symbicort | $32 | $91,840148 claims |
| Novo NordiskOzempic | $141 | $90,67891 claims |
| Boehringer IngelheimJardiance | $124 | $75,62188 claims |
| AbbVieLinzess | $751 | $33,74847 claims |
| GSKAnoro Ellipta | $17 | $7,86417 claims |
| MerckDulera | $15 | $3,91711 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 3,610 family providers in Louisiana.
Other family in Lake Charles
- Darci PortieLake Charles$63K
- Clay HillLake Charles$13K
- Alisha BernardLake Charles$13K
- Rebecca EzellSlidell$268K
- Erin PierceNew Orleans$261K
- Tavell KindallNew Orleans$194K
- Ashlea HillRuston$169K
- Brittany MillerVille Platte$158K
- Ryanne ClarkeGretna$123K
- Elidia DewittBaton Rouge$108K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.